Complex Immunotherapy-mediated Response Patterns Depicted on Serial ۱۸F-FDG PET imaging of Hodgkin Lymphoma Patient Undergoing Pembrolizumab Therapy
سال انتشار: 1404
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 19
فایل این مقاله در 5 صفحه با فرمت PDF قابل دریافت می باشد
- صدور گواهی نمایه سازی
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_JNMB-13-2_008
تاریخ نمایه سازی: 11 خرداد 1404
چکیده مقاله:
Over the past decade, the role of ۱۸F-Fluorodeoxyglucose (۱۸F-FDG) positron emission tomography/computed tomography (PET/CT) in assessing treatment response for lymphoma patients undergoing immunotherapy has been extensively investigated. The advent of immunotherapy has challenged the utility of the established Lugano criteria, prompting the development of novel immunotherapy-specific response criteria now employed in clinical practice. Following ۱۸F-FDG PET/CT evaluation after up to eight immunotherapy cycles, patients are typically transitioned to conventional imaging modalities if immunotherapy continuation is warranted. This case report illustrates the application of serial ۱۸F-FDG PET/CT in monitoring a ۶۷-year-old patient with Hodgkin lymphoma receiving immunotherapy, revealing complex, atypical response patterns unresolved by existing criteria. Notably, two episodes of pseudoprogression occurred at two distinct time points, one during cycle ۵ and the other during cycle ۲۲. Furthermore, an immunotherapy-enhanced abscopal effect was seen during radio-immunotherapy, leading to short-term disease remission. Our findings suggest that ۱۸F-FDG PET/CT provides superior predictive value in delineating heterogeneous response patterns, thereby informing critical decisions regarding immunotherapy cessation or adjunctive therapeutic interventions.
کلیدواژه ها:
نویسندگان
Mohanad Badarneh
Department of Nuclear Medicine, King Hussein Cancer Center (KHCC), Amman ۱۱۹۴۱, Jordan
Ahmed Abdlkadir
Department of Nuclear Medicine and PET/CT, King Hussein Cancer Center (KHCC), Amman, Jordan
Mohammad Makoseh
Department of Medicine, King Hussein Cancer Center (KHCC), Amman ۱۱۹۴۱, Jordan
Alaa Abufara
Department of Medicine, King Hussein Cancer Center (KHCC), Amman ۱۱۹۴۱, Jordan
Akram Al-Ibraheem
King Hussein Cancer Center